Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Zoidakis

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Proteomics. Clinical Applications|January 12, 2019
Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder CancerElena Critselis, Marta Rava, Mirari Marquez, et al.
Scientific Reports|May 12, 2016
Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findingsAgnieszka Latosinska, Manousos Makridakis, Maria Frantzi, et al.
Proteomics. Clinical Applications|August 23, 2022
Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non-responders' tumor tissueTamara Babic, Vasiliki Lygirou, Jovana Rosic, et al.
Biomedicines|February 25, 2022
Proteomic Analysis of Mouse Kidney Tissue Associates Peroxisomal Dysfunction with Early Diabetic Kidney DiseaseAggeliki Tserga, Despoina Pouloudi, Jean Sébastien Saulnier-Blache, et al.
Proteomics|May 20, 2026
Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple MyelomaMaria Frantzi, Melika Ahangar, Antonia Vlahou, et al.
Frontiers in Genetics|January 30, 2024
Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapyAleksandra Stanojevic, Jelena Spasic, Mladen Marinkovic, et al.
International Journal of Biological Sciences|February 16, 2026
TRPV1 Downregulation Impairs Prostate Cancer Growth: Functional and Translational Insights from Cellular and <i>In Vivo</i> ModelsBelén G Sánchez, José M Mora-Rodríguez, Alicia Bort, et al.
Scientific Reports|August 24, 2017
Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysisMagdalena Krochmal, Katryna Cisek, Szymon Filip, et al.
Journal of Proteome Research|August 9, 2013
IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkersMaria Frantzi, Jerome Zoidakis, Theofilos Papadopoulos, et al.
Journal of Clinical Medicine|January 23, 2024
Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy PredictionMladen Marinkovic, Suzana Stojanovic-Rundic, Aleksandra Stanojevic, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Proteomics. Clinical Applications|January 12, 2019
Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder CancerElena Critselis, Marta Rava, Mirari Marquez, et al.
Scientific Reports|May 12, 2016
Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findingsAgnieszka Latosinska, Manousos Makridakis, Maria Frantzi, et al.
Proteomics. Clinical Applications|August 23, 2022
Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non-responders' tumor tissueTamara Babic, Vasiliki Lygirou, Jovana Rosic, et al.
Biomedicines|February 25, 2022
Proteomic Analysis of Mouse Kidney Tissue Associates Peroxisomal Dysfunction with Early Diabetic Kidney DiseaseAggeliki Tserga, Despoina Pouloudi, Jean Sébastien Saulnier-Blache, et al.
Proteomics|May 20, 2026
Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple MyelomaMaria Frantzi, Melika Ahangar, Antonia Vlahou, et al.
Frontiers in Genetics|January 30, 2024
Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapyAleksandra Stanojevic, Jelena Spasic, Mladen Marinkovic, et al.
International Journal of Biological Sciences|February 16, 2026
TRPV1 Downregulation Impairs Prostate Cancer Growth: Functional and Translational Insights from Cellular and <i>In Vivo</i> ModelsBelén G Sánchez, José M Mora-Rodríguez, Alicia Bort, et al.
Scientific Reports|August 24, 2017
Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysisMagdalena Krochmal, Katryna Cisek, Szymon Filip, et al.
Journal of Proteome Research|August 9, 2013
IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkersMaria Frantzi, Jerome Zoidakis, Theofilos Papadopoulos, et al.
Journal of Clinical Medicine|January 23, 2024
Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy PredictionMladen Marinkovic, Suzana Stojanovic-Rundic, Aleksandra Stanojevic, et al.
Pageof 9